Question: Massachusetts Subscriber Answer: Key: Medicare spells out coverage requirements for restaging -- which occurs after the patient completes a course of treatment -- in its National Coverage Determinations Manual, chapter 1, part 4, section 220.6 (http://www.cms.hhs.gov/manuals/downloads/ncd103c1_Part4.pdf). For restaging, Medicare covers PET: 1. to detect residual disease after completing treatment 2. to detect suspected recurrence or metastasis 3. to determine the extent of a known recurrence or 4. to replace conventional imaging studies when the physician expects that conventional study information is insufficient for the patient's clinical management.